Drug or treatment

Siplizumab clinical trials

As of November 12, 2026, Find a Trial lists 3 clinical trials of Siplizumab that are recruiting, at sites in 3 countries (most in United States (3), Brazil (1), Spain (1)). By phase: Phase 2 (1), Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Siplizumab vs rATG for kidney transplant induction Phase 2 Los Angeles, California and 23 other locations Recruiting Apr 2, 2026
Using Siplizumab to prevent immune issues in liver transplant patients with autoimmune liver disease Phase 1 New York, New York Recruiting Jun 12, 2024
Evaluating Siplizumab for Hidradenitis Suppurativa Treatment Early Phase 1 Birmingham, Alabama Recruiting Mar 22, 2024

All recruiting trials (3)

Quick answers

How many clinical trials of Siplizumab are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (3 trials), Brazil (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.